{"product_id":"life-threatening-effects-of-antipsychotic-drugs-hardback-9780128033760","title":"Life-Threatening Effects of Antipsychotic Drugs (Hardback) 9780128033760","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eLife-Threatening Effects of Antipsychotic Drugs\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThis book is an essential reference text for psychiatrists, pathologists and any physician treating a psychiatric patient with a life-threatening condition. It would also be useful to primary care physicians with patients taking antipsychotic medication. \u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003ePeter Manu (Edited by), Robert J. Flanagan (Edited by), Kathlyn J. Ronaldson (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128033760, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 16 August 2016\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e394 pages\u003cbr\u003e22.9 x 15.1 x 2.6 cm, 0.77 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"… this book …presents important evidence-based information on side effects of antipsychotic drugs and how to prevent and counteract these. The book is organized in seven parts, all of them dealing with adverse effects of antipsychotic drugs in different organ systems: cardiovascular adverse effects, haematological complications, the digestive system, neurological and neuromuscular, metabolic complications, other life-threatening effects such as interstitial diseases in kidney and lung and, finally, a chapter dealing with clinical and forensic challenges in the use of antipsychotic drugs.\u003c\/p\u003e \u003cp\u003eAll subjects are treated in a consistent manner, starting with an epidemiological overview, followed by some background regarding pathobiology, continuing over clinical signs to management, ending up with suggestions for prevention of the conditions. The book has a richness of tables and figures facilitating the reading and understanding of the book’s important information and many messages of, e.g. Hazard ratios, odds ratios, clinical algorithms, all making it easily accessible.\u003c\/p\u003e \u003cp\u003e… The book is highly relevant to the clinically working psychiatrist, his\/her assistants, medical students and other with interest in the interphase between psychiatric illnesses, somatic diseases, their treatment and the always present balance between effect and side effects of treatments.\" \u003cb\u003e--Mikkel Hojlund, Povl Munk-Jørgensen, Nordic Journal of Psychiatry\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eLife-Threatening Effects of Antipsychotic Drugs \u003c\/i\u003edescribes in detail more than 20 life-threatening effects associated with antipsychotics, presents the best available data on their incidence and case fatality, and gives comprehensive advice on diagnosis, management and preventive strategies. In addition, the book discusses the benefit of antipsychotic medication in a range of therapeutic indications, and demonstrates the gain in life-expectancy associated with clozapine use in severe mental illness despite its serious, potentially life-threatening adverse effects. \u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePart I: Cardiovascular Adverse Effects of Antipsychotic Drugs\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 1 - Sudden Cardiac Death and Ventricular Arrhythmias\u003c\/p\u003e \u003cp\u003ePeter Manu, Anca Dan and Gheorghe-Andrei Dan\u003c\/p\u003e \u003cp\u003eChapter 2 - Myocarditis and Cardiomyopathy\u003c\/p\u003e \u003cp\u003eKathlyn J. Ronaldson\u003c\/p\u003e \u003cp\u003eChapter 3 - Pulmonary Embolism\u003c\/p\u003e \u003cp\u003ePeter Manu, Christopher Hohman, James F. Barrecchia, and Matisyahu Shulman\u003c\/p\u003e \u003cp\u003eChapter 4 - Orthostatic Hypotension\u003c\/p\u003e \u003cp\u003eJames J. Gugger and Megan J. Ehret\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Hematological Complications of Treatment With Antipsychotic Drugs\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 5 - Severe Neutropenia and Agranulocytosis\u003c\/p\u003e \u003cp\u003eJohn Lally and Robert J. Flanagan\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Antipsychotic-Related Pathology of the Digestive System\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 6 - Gastrointestinal Hypomotility and Dysphagia\u003c\/p\u003e \u003cp\u003eRobert J. Flanagan and Kathlyn J. Ronaldson\u003c\/p\u003e \u003cp\u003eChapter 7 - Liver Failure\u003c\/p\u003e \u003cp\u003eKatie F.M. Marwick\u003c\/p\u003e \u003cp\u003e8. Pancreatitis\u003c\/p\u003e \u003cp\u003ePeter Manu, Matisyahu Shulman and Kathlyn J. Ronaldson\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV: Major Neurological and Neuromuscular Adverse Effects of Antipsychotic Drugs\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 9 - Seizures\u003c\/p\u003e \u003cp\u003eTilman Steinert and Walter Fröscher\u003c\/p\u003e \u003cp\u003eChapter 10 - Neuroleptic Malignant Syndrome\u003c\/p\u003e \u003cp\u003eJulie Langan Martin and Daniel J. Martin\u003c\/p\u003e \u003cp\u003eChapter 11 - Heat Stroke and Rhabdomyolysis\u003c\/p\u003e \u003cp\u003eKathlyn J. Ronaldson\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V: Metabolic Complications of Antipsychotic Drug Treatment\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 12 - Type 2 Diabetes Mellitus\u003c\/p\u003e \u003cp\u003eDavy Vancampfort, Richard I.G. Holt, Brendon Stubbs, Marc De Hert, Katherine Samaras and Alex J. Mitchell\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI: Other Life-Threatening Effects of Antipsychotic Drugs\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 13 - Interstitial Nephritis and Interstitial Lung Disease\u003c\/p\u003e \u003cp\u003eKathlyn J. Ronaldson\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VII: Clinical and Forensic Challenges in the Use of Antipsychotic Drugs\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 14 - The Benefits of Antipsychotic Drugs: Symptom Control and Improved Quality of Life\u003c\/p\u003e \u003cp\u003eJian-Ping Zhang\u003c\/p\u003e \u003cp\u003eChapter 15 - Antipsychotic-Related Mortality: Risk and Strategy for Improved Clinical Management\u003c\/p\u003e \u003cp\u003eDan Cohen\u003c\/p\u003e \u003cp\u003eChapter 16 - Forensic Investigation of Antipsychotic-Related Deaths\u003c\/p\u003e \u003cp\u003eRobert J. Flanagan and Peter Manu\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Psychopharmacology [\u003ca title=\"See our other books on Psychopharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Psychopharmacology%20%5BMMGW%5D%22\"\u003eMMGW\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648817746200,"sku":"9780128033760","price":67.39,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128033760.jpg?v=1694094406","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/life-threatening-effects-of-antipsychotic-drugs-hardback-9780128033760","provider":"Freshly Printed Books","version":"1.0","type":"link"}